Scientists Discover Natural "Brake" to Stop Inflammation

Scientists at University College London have found what might be the body's built-in "off switch" for inflammation, offering new hope for millions living with chronic conditions.

The research team discovered that tiny fat-derived molecules called epoxy-oxylipins act as natural brakes on our immune system. When these molecules are allowed to build up instead of being broken down, they can stop inflammation in its tracks.

To test their theory, researchers recruited 48 healthy volunteers and triggered a controlled inflammatory response similar to what happens after an infection. Half received an experimental drug that blocks the enzyme responsible for breaking down these helpful molecules, while the other half got a placebo.

The results were promising. People who took the medication experienced faster pain relief than those who didn't. Scientists also noticed a significant drop in monocytes, the immune cells that drive chronic inflammation and contribute to disease.

The real breakthrough came when researchers identified exactly how the process works. One specific molecule, called 12,13-EpOME, shuts down a protein that transforms monocytes, effectively putting the brakes on runaway inflammation.

This matters because chronic inflammation affects about 60% of deaths worldwide. It fuels everything from heart disease and diabetes to dementia and arthritis. As we age, our cells naturally pump out inflammatory proteins that damage tissues and organs over time.

The Bright Side

Unlike many scientific discoveries that take decades to reach patients, this drug is already ready for clinical trials. Lead researcher Derek Gilroy says his team is particularly interested in testing it for lupus and other autoimmune diseases where the immune system attacks healthy tissue.

But the potential goes beyond treating specific conditions. Dr. Michael Aziz, an internist at Northwell Lenox Hill Hospital, believes this approach could eventually tackle the symptoms of aging itself by addressing one of its root causes.

The study shows the medication worked whether given before or after inflammation started, meaning it could both prevent and treat flare-ups in real-world situations.

While lifestyle changes like eating whole foods, exercising regularly, managing stress, and getting enough sleep can help reduce inflammation risk, people with autoimmune disorders need medical solutions. This discovery could offer relief where prevention isn't enough.

Clinical trials are the next step toward bringing this treatment to patients who need it most.